Matrix metalloproteinase-9 involvement in the structural plasticity of dendritic spines

Michał Stawarski1, Marzena Stefaniuk2, Jakub Włodarczyk1
1Laboratory of Cell Biophysics, Department of Molecular and Cellular Neurobiology, Nencki Institute of Experimental Biology Warsaw, Mazowieckie, Poland.
2Laboratory of Neurobiology, Department of Molecular and Cellular Neurobiology, Nencki Institute of Experimental Biology Warsaw, Mzowieckie, Poland.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Abdallah, 2013, Matrix metalloproteinases in autism spectrum disorders, J. Mol. Psychiatry, 1, 16, 10.1186/2049-9256-1-16

Abdallah, 2012, Amniotic fluid MMP-9 and neurotrophins in autism spectrum disorders: an exploratory study, Autism Res., 5, 428, 10.1002/aur.1254

Akers, 2012, Detection of MMP-2 and MMP-9 activity in vivo with a triple-helical peptide optical probe, Bioconjug. Chem., 23, 656, 10.1021/bc300027y

Akool, 2003, Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR, Mol. Cell. Biol., 23, 4901, 10.1128/mcb.23.14.4901-4916.2003

Ampuero, 2007, Status epilepticus induces region-specific changes in dendritic spines, dendritic length and TrkB protein content of rat brain cortex, Brain Res., 1150, 225, 10.1016/j.brainres.2007.02.089

Araque, 1999, Tripartite synapses: glia, the unacknowledged partner, Trends Neurosci., 22, 208, 10.1016/s0166-2236(98)01349-6

Araya, 2006, The spine neck filters membrane potentials, Proc. Natl. Acad. Sci. U S A, 103, 17961, 10.1073/pnas.0608755103

Backstrom, 1996, Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-β peptide (1–40), J. Neurosci., 16, 7910, 10.1523/JNEUROSCI.16-24-07910.1996

Bagni, 2012, Fragile X syndrome: causes, diagnosis, mechanisms and therapeutics, J. Clin. Invest., 122, 4314, 10.1172/JCI63141

Bajor, 2012, Synaptic cell adhesion molecule-2 and collapsing response mediator protein-2 are novel members of the matrix metalloproteinase-9 degradome, J. Neurochem., 122, 775, 10.1111/j.1471-4159.2012.07829.x

Banerjee, 2008, Incidence and prevalence, Epilepsy. A Comprehensive Textbook, 45

Baracskay, 2008, Generalization of seizures parallels the formation of “dark” neurons in the hippocampus and pontine reticular formation after focal-cortical application of 4-aminopyridine (4-AP) in the rat, Brain Res., 1228, 217, 10.1016/j.brainres.2008.06.044

Becker, 1995, Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme, Protein Sci., 4, 1966, 10.1002/pro.5560041002

Berg, 2011, Epilepsy, cognition and behavior: the clinical picture, Epilepsia, 52, 7, 10.1111/j.1528-1167.2010.02905.x

Bilousova, 2009, Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model, J. Med. Genet., 46, 94, 10.1136/jmg.2008.061796

Blümcke, 1999, Cellular pathology of hilar neurons in Ammon’s horn sclerosis, J. Comp. Neurol., 414, 437, 10.1002/(sici)1096-9861(19991129)414:4437::aid-cne23.0.co;2-3

Bode, 1999, Endoproteinase-protein inhibitor interactions, APMIS, 107, 3, 10.1111/j.1699-0463.1999.tb01520.x

Bolkvadze, 2012, Development of post-traumatic epilepsy after controlled cortical impact and lateral fluid-percussion-induced brain injury in the mouse, J. Neurotrauma, 29, 789, 10.1089/neu.2011.1954

Bourguignon, 1998, CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression, Front. Biosci., 3, d637, 10.2741/A308

Bowe, 1994, Identification and purification of an agrin receptor from Torpedo postsynaptic membranes: a heteromeric complex related to the dystroglycans, Neuron, 12, 1173, 10.1016/0896-6273(94)90324-7

Bozdagi, 2007, In vivo roles for matrix metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity, J. Neurophysiol., 98, 334, 10.1152/jn.00202.2007

Brown, 2008a, Increase in matrix metalloproteinase-9 levels in the rat medial prefrontal cortex after cocaine reinstatement of conditioned place preference, Synapse, 62, 886, 10.1002/syn.20562

Brown, 2008b, Rapid morphologic plasticity of peri-infarct dendritic spines after focal ischemic stroke, Stroke, 39, 1286, 10.1161/STROKEAHA.107.498238

Bruno, 2006, Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor and its degradation by a protease cascade, Proc. Natl. Acad. Sci. U S A, 103, 6735, 10.1073/pnas.0510645103

Campanelli, 1996, Alternative RNA splicing that determines agrin activity regulates binding to heparin and α-dystroglycan, Development, 122, 1663, 10.1242/dev.122.5.1663

Campbell, 2012, Mechanisms of dendritic spine remodeling in rat model of traumatic brain injury, J. Neurotrauma, 29, 218, 10.1089/neu.2011.1762

Cao, 2014, Early enriched environment induces an increased conversion of proBDNF to BDNF in the adults rat’s hippocampus, Behav. Brain Res., 265, 76, 10.1016/j.bbr.2014.02.022

Cha, 2002, Structural basis of the adaptive molecular recognition by MMP9, J. Mol. Biol., 320, 1065, 10.1016/s0022-2836(02)00558-2

Chung, 2013, Structural and molecular interrogation of intact biological systems, Nature, 497, 332, 10.1038/nature12107

Coenen, 2003, Genetic animal models for absence epilepsy: a review of the WAG/Rij strain of rats, Behav. Genet., 33, 635, 10.1023/A:1026179013847

Comery, 1997, Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits, Proc. Natl. Acad. Sci. U S A, 94, 5401, 10.1073/pnas.94.10.5401

Conant, 2011, Methamphetamine-associated cleavage of the synaptic adhesion molecule intercellular adhesion molecule-5, J. Neurochem., 118, 521, 10.1111/j.1471-4159.2010.07153.x

Conant, 2010, Matrix metalloproteinase-dependent shedding of intercellular adhesion molecule-5 occurs with long-term potentiation, Neuroscience, 166, 508, 10.1016/j.neuroscience.2009.12.061

Czech, 2004, Reduction of hippocampal collapsin response mediated protein-2 in patients with mesial temporal lobe epilepsy, Neurochem. Res., 29, 2189, 10.1007/s11064-004-7025-3

Dansie, 2011, Casting a net on dendritic spines: the extracellular matrix and its receptors, Dev. Neurobiol., 71, 956, 10.1002/dneu.20963

De Leo, 2006, The tetrapartite synapse: path to CNS sensitization and chronic pain, Pain, 122, 17, 10.1016/j.pain.2006.02.034

De Paiva, 2009, Cleavage of functional IL-2 receptor alpha chain (CD25) from murine corneal and conjunctival epithelia by MMP-9, J. Inflamm. (Lond), 6, 31, 10.1186/1476-9255-6-31

de Vivo, 2013, Extracellular matrix inhibits structural and functional plasticity of dendritic spines in the adult visual cortex, Nat. Commun., 4, 1484, 10.1038/ncomms2491

Dityatev, 2010, Remodeling of extracellular matrix and epileptogenesis, Epilepsia, 51, 61, 10.1111/j.1528-1167.2010.02612.x

Dityatev, 2011, Molecular signals of plasticity at the tetrapartite synapse, Curr. Opin. Neurobiol., 21, 353, 10.1016/j.conb.2010.12.006

Dityatev, 2010, The dual role of the extracellular matrix in synaptic plasticity and homeostasis, Nat. Rev. Neurosci., 11, 735, 10.1038/nrn2898

Dodrill, 2002, Progressive cognitive decline in adolescents and adults with epilepsy, Prog. Brain Res., 135, 399, 10.1016/s0079-6123(02)35037-4

Dziembowska, 2012, Activity-dependent local translation of matrix metalloproteinase-9, J. Neurosci., 32, 14538, 10.1523/JNEUROSCI.6028-11.2012

Dziembowska, 2013, High MMP-9 activity levels in fragile X syndrome are lowered by minocycline, Am. J. Med. Genet. A, 161A, 1897, 10.1002/ajmg.a.36023

Elger, 2004, Chronic epilepsy and cognition, Lancet Neurol., 3, 663, 10.1016/S1474-4422(04)00906-8

Ervasti, 1993, A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin, J. Cell Biol., 122, 809, 10.1083/jcb.122.4.809

Ethell, 2007, Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets, J. Neurosci. Res., 85, 2813, 10.1002/jnr.21273

Faust, 2008, Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases, Bioconjug. Chem., 19, 1001, 10.1021/bc700409j

Filippov, 2012, Matrix metalloproteinase-9 and non-amyloidogenic pathway of amyloid precursor protein processing, J. Neurochem., 121, 181, 10.1111/j.1471-4159.2011.07641.x

Fogel, 2007, SynCAMs organize synapses through heterophilic adhesion, J. Neurosci., 27, 12516, 10.1523/jneurosci.2739-07.2007

Foscarin, 2011, Experience-dependent plasticity and modulation of growth regulatory molecules at central synapses, PLoS One, 6, e16666, 10.1371/journal.pone.0016666

Freiman, 2011, Granule cell dispersion in temporal lobe epilepsy is associated with changes in dendritic orientation and spine distribution, Exp. Neurol., 229, 332, 10.1016/j.expneurol.2011.02.017

Fudala, 2011, Fluorescence detection of MMP-9: I. MMP-9 selectively cleaves Lys-Gly-Pro-Arg-Ser-Leu-Ser-Gly-Lys peptide, Curr. Pharm. Biotechnol., 12, 834, 10.2174/138920111795470967

Fukata, 2002, CRMP-2 binds to tubulin heterodimers to promote microtubule assembly, Nat. Cell Biol., 4, 583, 10.1038/ncb825

Gallyas, 2008, The mode of death of epilepsy-induced “dark” neurons is neither necrosis nor apoptosis: an electron-microscopic study, Brain Res., 1239, 207, 10.1016/j.brainres.2008.08.069

Ganguly, 2013, Matrix metalloproteinases (MMP) 9 transcription in mouse brain induced by fear learning, J. Biol. Chem., 288, 20978, 10.1074/jbc.m113.457903

Gawlak, 2009, High resolution in situ zymography reveals matrix metalloproteinase activity at glutamatergic synapses, Neuroscience, 158, 167, 10.1016/j.neuroscience.2008.05.045

Gee, 1993, Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan and binds with high affinity to the major heparin binding domain of laminin, J. Biol. Chem., 268, 14972, 10.1016/S0021-9258(18)82427-9

Glausier, 2013, Dendritic spine pathology in schizophrenia, Neuroscience, 251, 90, 10.1016/j.neuroscience.2012.04.044

González-Burgos, 2004, Density, but not shape, of hippocampal dendritic spines varies after a seizure-inducing acute dose of monosodium glutamate in rats, Neurosci. Lett., 363, 22, 10.1016/j.neulet.2004.03.035

Gorkiewicz, 2010, Matrix metalloproteinase-9 reversibly affects the time course of NMDA-induced currents in cultured rat hippocampal neurons, Hippocampus, 20, 1105, 10.1002/hipo.20736

Grossetete, 2009, Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury, Neurosurgery, 65, 702, 10.1227/01.neu.0000351768.11363.48

Gu, 2000, Evidence that collapsin response mediator protein-2 is involved in the dynamics of microtubules, J. Biol. Chem., 275, 17917, 10.1074/jbc.c000179200

Gustafson, 2013, Synthesis and characterization of a matrix-metalloproteinase responsive silk-elastinlike protein polymer, Biomacromolecules, 14, 618, 10.1021/bm3013692

Hadass, 2013, Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injury, PLoS One, 8, e76904, 10.1371/journal.pone.0076904

Hagerman, 2005, Recent advances in fragile X: a model for autism and neurodegeneration, Curr. Opin. Psychiatry, 18, 490, 10.1097/01.yco.0000179485.39520.b0

Hahn-Dantona, 2001, The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism, J. Biol. Chem., 276, 15498, 10.1074/jbc.m100121200

Hama, 2011, Scale: a chemical approach for fluorescence imaging and reconstruction of transparent mouse brain, Nat. Neurosci., 14, 1481, 10.1038/nn.2928

Harris, 1989, Dendritic spines of CA1 pyramidal cells in the rat hippocampus: serial electron microscopy with reference to their biophysical characteristics, J. Neurosci., 9, 2982, 10.1523/JNEUROSCI.09-08-02982.1989

Hasebe, 2007, Induction of matrix metalloproteinase gene expression in an endothelial cell line by direct interaction with malignant cells, Cancer Sci., 98, 58, 10.1111/j.1349-7006.2006.00344.x

Helmstaedter, 2002, Effects of chronic epilepsy on declarative memory systems, Prog. Brain Res., 135, 439, 10.1016/s0079-6123(02)35041-6

Henry, 2001, Distinct roles for dystroglycan, β1 integrin and perlecan in cell surface laminin organization, J. Cell Sci., 114, 1137, 10.1242/jcs.114.6.1137

Hill, 2012, Intranuclear matrix metalloproteinases promote DNA damage and apoptosis induced by oxygen-glucose deprivation in neurons, Neuroscience, 220, 277, 10.1016/j.neuroscience.2012.06.019

Hsieh, 2014, Up-regulation of ROS-dependent matrix metalloproteinase-9 from high-glucose-challenged astrocytes contributes to the neuronal apoptosis, Mol. Neurobiol., 10.1007/s12035-013-8628-y

Huntley, 2012, Synaptic circuit remodelling by matrix metalloproteinases in health and disease, Nat. Rev. Neurosci., 13, 743, 10.1038/nrn3320

Hwang, 2005, Activation of the Trk signaling pathway by extracellular zinc: role of metalloproteinases, J. Biol. Chem., 280, 11995, 10.1074/jbc.m403172200

Inagaki, 2001, CRMP-2 induces axons in cultured hippocampal neurons, Nat. Neurosci., 4, 781, 10.1038/90476

Isokawa, 2000, Remodeling dendritic spines of dentate granule cells in temporal lobe epilepsy patients and the rat pilocarpine model, Epilepsia, 41, S14, 10.1111/j.1528-1157.2000.tb01550.x

Jaworski, 1999, Neuronal excitation-driven and AP-1-dependent activation of tissue inhibitor of metalloproteinases-1 gene expression in rodent hippocampus, J. Biol. Chem., 274, 28106, 10.1074/jbc.274.40.28106

Jiang, 1998, Spine loss and other persistent alterations of hippocampal pyramidal cell dendrites in a model of early-onset epilepsy, J. Neurosci., 18, 8356, 10.1523/JNEUROSCI.18-20-08356.1998

Jourquin, 2003, Neuronal activity-dependent increase of net matrix metalloproteinase activity is associated with MMP-9 neurotoxicity after kainate, Eur. J. Neurosci., 18, 1507, 10.1046/j.1460-9568.2003.02876.x

Kaczmarek, 2013, MMP-9 inhibitors in the brain: can old bullets shoot new targets?, Curr. Pharm. Des., 19, 1085, 10.2174/1381612811319060010

Kaczmarek, 2002, Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections?, EMBO J., 21, 6643, 10.1093/emboj/cdf676

Kaijzel, 2010, Multimodality imaging reveals a gradual increase in matrix metalloproteinase activity at aneurysmal lesions in live fibulin-4 mice, Circ. Cardiovasc. Imaging, 3, 567, 10.1161/circimaging.109.933093

Kaliszewska, 2012, Experience-dependent plasticity of the barrel cortex in mice observed with 2-DG brain mapping and c-Fos: effects of MMP-9 KO, Cereb. Cortex, 22, 2160, 10.1093/cercor/bhr303

Kharazia, 1999, Immunogold localization of AMPA and NMDA receptors in somatic sensory cortex of albino rat, J. Comp. Neurol., 412, 292, 10.1002/(sici)1096-9861(19990920)412:2292::aid-cne83.0.co;2-g

Kim, 2006, Remodeling of synaptic structure in the motor cortex following spinal cord injury, Exp. Neurol., 198, 401, 10.1016/j.expneurol.2005.12.010

Kim, 2009, The role of MMP-9 in integrin-mediated hippocampal cell death after pilocarpine-induced status epilepticus, Neurobiol. Dis., 36, 169, 10.1016/j.nbd.2009.07.008

Kim, 2012, Matrix metalloproteinase 9 (MMP-9)-dependent processing of βig-h3 protein regulates cell migration, invasion and adhesion, J. Biol. Chem., 287, 38957, 10.1074/jbc.M112.357863

Kitaura, 2011, Spatiotemporal dynamics of epileptiform propagations: imaging of human brain slices, Neuroimage, 58, 50, 10.1016/j.neuroimage.2011.05.046

Kjeldsen, 1993, Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase, J. Biol. Chem., 268, 10425, 10.1016/S0021-9258(18)82217-7

Klein, 2004, Eph/ephrin signaling in morphogenesis, neural development and plasticity, Curr. Opin. Cell Biol., 16, 580, 10.1016/j.ceb.2004.07.002

Konopacki, 2007, Synaptic localization of seizure-induced matrix metalloproteinase-9 mRNA, Neuroscience, 150, 31, 10.1016/j.neuroscience.2007.08.026

Konopka, 2013, Matrix metalloproteinase-9 (MMP-9) in human intractable epilepsy caused by focal cortical dysplasia, Epilepsy Res., 104, 45, 10.1016/j.eplepsyres.2012.09.018

Kovács, 2011, Doxycycline could aggravate the absence-like epileptic seizures of WAG/Rij rats via matrix metalloproteinase inhibition, Neurochem. Int., 59, 563, 10.1016/j.neuint.2011.06.016

Kowluru, 2011, Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage, Diabetes, 60, 3023, 10.2337/db11-0816

Kuzniewska, 2013, Brain-derived neurotrophic factor induces matrix metalloproteinases-9 expression in neurons via the the serum response factor/c-Fos pathway, Mol. Cell. Biol., 33, 2149, 10.1128/MCB.00008-13

Labrie, 2013, Epigenetic regulation of mmp-9 gene expression, Cell. Mol. Life Sci., 70, 3109, 10.5713/ajas.2012.12529

Larsen, 2003, Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan, J. Neurosci., 23, 11127, 10.1523/JNEUROSCI.23-35-11127.2003

Lee, 2012, Optical imaging of MMP expression and cancer progression in an inflammation-induced colon cancer model, Int. J. Cancer, 131, 1846, 10.1002/ijc.27451

Leigh, 2013, A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile × syndrome, J. Dev. Behav. Pediatr., 34, 147, 10.1097/DBP.0b013e318287cd17

Lin, 2008, Ephrin-B2-induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsion, J. Biol. Chem., 283, 28969, 10.1074/jbc.M804401200

Liu, 2008, Relationship between methamphetamine exposure and matrix metalloproteinase 9 expression, Neuroreport, 19, 1407, 10.1097/WNR.0b013e32830dd606

Lonskaya, 2013, Soluble ICAM-5, a product of activity dependent proteolysis, increases mEPSC frequency and dendritic expression of GluA1, PLoS One, 8, e69136, 10.1371/journal.pone.0069136

Lukasiuk, 2011, Extracellular proteases in epilepsy, Epilepsy Res., 96, 191, 10.1016/j.eplepsyres.2011.08.002

Meighan, 2006, Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity, J. Neurochem., 96, 1227, 10.1111/j.1471-4159.2005.03565.x

Meyer, 2014, Balance and stability of synaptic structures during synaptic plasticity, Neuron, 82, 430, 10.1016/j.neuron.2014.02.031

Michaluk, 2007, Matrix metalloproteinase-9 in glutamate-dependent adult brain function and dysfunction, Cell Death Differ., 14, 1255, 10.1038/sj.cdd.4402141

Michaluk, 2007, β-dystroglycan as a target for MMP-9, in response to enhanced neuronal activity, J. Biol. Chem., 282, 16036, 10.1074/jbc.m700641200

Michaluk, 2009, Matrix metalloproteinase-9 controls NMDA receptor surface diffusion through integrin beta1 signaling, J. Neurosci., 29, 6007, 10.1523/JNEUROSCI.5346-08.2009

Michaluk, 2011, Influence of matrix metalloproteinase MMP-9 on dendritic spine morphology, J. Cell Sci., 124, 3369, 10.1242/jcs.090852

Mizoguchi, 2011a, Matrix metalloproteinase-9 contributes to kindled seizure development in pentylenetetrazole-treated mice by converting pro-BDNF to mature BDNF in the hippocampus, J. Neurosci., 31, 12963, 10.1523/JNEUROSCI.3118-11.2011

Mizoguchi, 2011b, Matrix metalloproteinases contribute to neuronal dysfunction in animal models of drug dependence, Alzheimer’s disease and epilepsy, Biochem. Res. Int., 2011, 681385, 10.1155/2011/681385

Mollayeva, 2013, Screening for sleep dysfunction after traumatic brain injury, Sleep Med., 14, 1235, 10.1016/j.sleep.2013.07.009

Morrison, 2009, Matrix metalloproteinase proteomics: substrates, targets and therapy, Curr. Opin. Cell Biol., 21, 645, 10.1016/j.ceb.2009.06.006

Multani, 1994, Neocortical dendritic pathology in human partial epilepsy: a quantitative Golgi study, Epilepsia, 35, 728, 10.1111/j.1528-1157.1994.tb02503.x

Murai, 2004, Eph receptors, ephrins and synaptic function, Neuroscientist, 10, 304, 10.1177/1073858403262221

Nagase, 1999, Matrix metalloproteinases, J. Biol. Chem., 274, 21491, 10.1074/jbc.274.31.21491

Nagy, 2006, Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory, J. Neurosci., 26, 1923, 10.1523/jneurosci.4359-05.2006

Nakamura, 2000, Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites, J. Biol. Chem., 275, 38885, 10.1074/jbc.m003875200

Nedivi, 1993, Numerous candidate plasticity-related genes revealed by differential cDNA cloning, Nature, 363, 718, 10.1038/363718a0

Nusser, 1998, Cell type and pathway dependence of synaptic AMPA receptor number and variability in the hippocampus, Neuron, 21, 545, 10.1016/s0896-6273(00)80565-6

Okulski, 2007, TIMP-1 abolishes MMP-9-dependent long-lasting long-term potentiation in the prefrontal cortex, Biol. Psychiatry, 62, 359, 10.1016/j.biopsych.2006.09.012

Overall, 2002, Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules and exosites, Mol. Biotechnol., 22, 51, 10.1385/mb:22:1:051

Pal-Ghosh, 2011, MMP9 cleavage of the β4 integrin ectodomain leads to recurrent epithelial erosions in mice, J. Cell Sci., 124, 2666, 10.1242/jcs.085480

Paribello, 2010, Open-label add-on treatment trial of minocycline in fragile × syndrome, BMC Neurol., 10, 91, 10.1186/1471-2377-10-91

Peixoto, 2012, Transsynaptic signaling by activity-dependent cleavage of neuroligin-1, Neuron, 76, 396, 10.1016/j.neuron.2012.07.006

Peng, 1998, The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction, Cell Adhes. Commun., 5, 475, 10.3109/15419069809005605

Penzes, 2011, Dendritic spine pathology in neuropsychiatric disorders, Nat. Neurosci., 14, 285, 10.1038/nn.2741

Pirici, 2012, Matrix metalloproteinase-9 expression in the nuclear compartment of neurons and glial cells in aging and stroke, Neuropathology, 32, 492, 10.1111/j.1440-1789.2011.01279.x

Ramón y Cajal, 1888, Estructura de los centros nerviosos de las aves, Rev. Trim. Histol. Norm. Pat., 1, 1

Ramón y Cajal, 1891, Sur la structure de l’écorce cérébrale de quelques mamifères, Cellule, 7, 124

Ramón y Cajal, 1893, Neue darstellung vom histologischen bau des centralnervensystem, Arch. Anat. Entwick. Anat. Abt. Suppl., 1893, 319

Ramón y Cajal, 1899, Estudios sobre la cortexa cerebral humana: corteza visual, Rev. Trim. Microgr., 4, 1

Represa, 1993, Epilepsy induced collateral sprouting of hippocampal mossy fibers: does it induce the development of ectopic synapses with granule cell dendrites?, Hippocampus, 3, 257, 10.1002/hipo.450030303

Rezaei, 2012, Effects of neurosurgical treatment and severity of head injury on cognitive functioning, general health and incidence of mental disorders in patients with traumatic brain injury, Arch. Trauma Res., 1, 93, 10.5812/atr.6546

Rivera, 2010, Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?, J. Neurosci., 30, 15337, 10.1523/JNEUROSCI.3467-10.2010

Roghani, 1999, Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity, J. Biol. Chem., 274, 3531, 10.1074/jbc.274.6.3531

Rosenblum, 2007, Insights into the structure and domain flexibility of full-length pro-matrix metalloproteinase-9/gelatinase B, Structure, 15, 1227, 10.1016/j.str.2007.07.019

Roy, 2011, Potential of fluorescent metalloproteinase substrates for cancer detection, Clin. Biochem., 44, 1434, 10.1016/j.clinbiochem.2011.09.016

Rudelli, 1985, Adult fragile X syndrome: clinico-neuropathologic findings, Acta Neuropathol., 67, 289, 10.1007/bf00687814

Rybakowski, 2013, Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression, J. Affect. Disord., 146, 286, 10.1016/j.jad.2012.07.019

Rylski, 2009, JunB is a repressor of MMP-9 transcription in depolarized rat brain neurons, Mol. Cell. Neurosci., 40, 98, 10.1016/j.mcn.2008.09.005

Rylski, 2008, Yin Yang 1 is a critical repressor of matrix metalloproteinase-9 expression in brain neurons, J. Biol. Chem., 283, 35140, 10.1074/jbc.M804540200

Sala, 2014, The locus of structural and functional plasticity, Physiol. Rev., 94, 141, 10.1152/physrev.00012.2013

Samochowiec, 2010, Functional polymorphism of matrix metalloproteinase-9 (MMP-9) gene in alcohol dependence: family and case control study, Brain Res., 1327, 103, 10.1016/j.brainres.2010.02.072

Sarkisova, 2011, The WAG/Rij strain: a genetic animal model of absence epilepsy with comorbidity of depression [corrected], Prog. Neuropsychopharmacol. Biol. Psychiatry, 35, 854, 10.1016/j.pnpbp.2010.11.010

Sbai, 2008, Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells, Mol. Cell. Neurosci., 39, 549, 10.1016/j.mcn.2008.08.004

Sbai, 2010, Differential vesicular distribution and trafficking of MMP-2, MMP-9 and their inhibitors in astrocytes, Glia, 58, 344, 10.1002/glia.20927

Scharfman, 2002, Epilepsy as an example of neural plasticity, Neuroscientist, 8, 154, 10.1177/107385840200800211

Scherer, 2008, Imaging matrix metalloproteinases in cancer, Cancer Metastasis Rev., 27, 679, 10.1007/s10555-008-9152-9

Schonbeck, 1998, Generation of biologically active IL-1β by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1β processing, J. Immunol., 161, 3340, 10.4049/jimmunol.161.7.3340

Shen, 2009, Altered dendritic spine elasticity in cocaine-withdrawn rats, J. Neurosci., 29, 2876, 10.1523/JNEUROSCI.5638-08.2009

Sheu, 2001, A novel role of metalloproteinase in cancer-mediated immunosuppression, Cancer Res., 61, 237

Spolidoro, 2012, Inhibition of matrix metalloproteinases prevents the potentiation of nondeprived-eye responses after monocular deprivation in juvenile rats, Cereb. Cortex, 22, 725, 10.1093/cercor/bhr158

Stawarski, 2014, Genetically encoded FRET-based biosensor for imaging MMP-9 activity, Biomaterials, 35, 1402, 10.1016/j.biomaterials.2013.11.033

Stute, 2003, Kinetic analysis of the binding of hemopexin-like domain of gelatinase B cloned and expressed in Pichia pastoris to tissue inhibitor of metalloproteinases-1, J. Protein Chem., 22, 509, 10.1023/b:jopc.0000005499.51466.50

Suenaga, 2008, Roles of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in acute encephalopathy following prolonged febrile seizures, J. Neurol. Sci., 266, 126, 10.1016/j.jns.2007.09.011

Sugita, 2001, A stoichiometric complex of neurexins and dystroglycan in brain, J. Cell Biol., 154, 435, 10.1083/jcb.200105003

Susaki, 2014, Whole-brain imaging with single-cell resolution using chemical cocktails and computational analysis, Cell, 157, 726, 10.1016/j.cell.2014.03.042

Suzuki, 1997, Correlated axonal sprouting and dendritic spine formation during kainate-induced neuronal morphogenesis in the dentate gyrus of adult mice, Exp. Neurol., 145, 203, 10.1006/exnr.1997.6469

Swann, 2000, Spine loss and other dendritic abnormalities in epilepsy, Hippocampus, 10, 617, 10.1002/1098-1063(2000)10:5617::aid-hipo133.3.co;2-i

Szepesi, 2013, Matrix metalloproteinases regulate the formation of dendritic spine head protrusions during chemically induced long-term potentiation, PLoS One, 8, e63314, 10.1371/journal.pone.0063314

Szepesi, 2014, Synaptically released matrix metalloproteinases activity in control of structural plasticity and the cel surface distribution of GluA1-AMPA receptors, PLoS One, 9, e98274, 10.1371/journal.pone.0098274

Szklarczyk, 2002, Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus, J. Neurosci., 22, 920, 10.1523/JNEUROSCI.22-03-00920.2002

Takacs, 2010, Matrix metalloproteinase-9 activity increased by two different types of epileptic seizures that do not induce neuronal death: a possible role in homeostatic synaptic plasticity, Neurochem. Int., 56, 799, 10.1016/j.neuint.2010.03.003

Takumi, 1999, Different modes of expression of AMPA and NMDA receptors in hippocampal synapses, Nat. Neurosci., 2, 618, 10.1038/10172

Tian, 2007, Activation of NMDA receptors promotes dendritic spine development through MMP-mediated ICAM-5 cleavage, J. Cell Biol., 178, 687, 10.1083/jcb.200612097

Tønnesen, 2014, Spine neck plasticity regulates compartmentalization of synapses, Nat. Neurosci., 17, 678, 10.1038/nn.3682

Tsien, 2013, Very long-term memories may be stored in the pattern of holes in the perineuronal net, Proc. Natl. Acad. Sci. U S A, 110, 12456, 10.1073/pnas.1310158110

Uchida, 2005, [Molecular mechanism of axon guidance mediated by phosphorylation of CRMP2], Seikagaku, 77, 1424

Utari, 2010, Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures, Am. J. Intellect. Dev. Disabil., 115, 433, 10.1352/1944-7558-115.5.433

Vaisar, 2009, MMP-9 sheds the β2 integrin subunit (CD18) from macrophages, Mol. Cell Proteomics, 8, 1044, 10.1074/mcp.m800449-mcp200

Van den Steen, 2000, Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4 and GRO-α and leaves RANTES and MCP-2 intact, Blood, 96, 2673, 10.1182/blood.V96.8.2673

Van den Steen, 2006, The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors, J. Biol. Chem., 281, 18626, 10.1074/jbc.m512308200

Van Wart, 1990, The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family, Proc. Natl. Acad. Sci. U S A, 87, 5578, 10.1073/pnas.87.14.5578

Vandooren, 2013, Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade, Crit. Rev. Biochem. Mol. Biol., 48, 222, 10.3109/10409238.2013.770819

Verslegers, 2013, Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system, Prog. Neurobiol., 105, 60, 10.1016/j.pneurobio.2013.03.004

Wallis de Vries, 2009, Multispectral near-infrared fluorescence molecular imaging of matrix metalloproteinases in a human carotid plaque using a matrix-degrading metalloproteinase-sensitive activatable fluorescent probe, Circulation, 119, e534, 10.1161/circulationaha.108.821389

Wang, 2000, Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury, J. Neurosci., 20, 7037, 10.1523/JNEUROSCI.20-18-07037.2000

Wang, 2008, Extracellular proteolysis by matrix metalloproteinase-9 drives dendritic spine enlargement and long-term potentiation coordinately, Proc. Natl. Acad. Sci. U S A, 105, 19520, 10.1073/pnas.0807248105

Wang, 2003, Ganglioside GM3 inhibits matrix metalloproteinase-9 activation and disrupts its association with integrin, J. Biol. Chem., 278, 25591, 10.1074/jbc.m302211200

Wiera, 2012, Long term potentiation affects intracellular metalloproteinases activity in the mossy fiber-CA3 pathway, Mol. Cell. Neurosci., 50, 147, 10.1016/j.mcn.2012.04.005

Wiera, 2013, Maintenance of long-term potentiation in hippocampal mossy fiber-CA3 pathway requires fine-tuned MMP-9 proteolytic activity, Hippocampus, 23, 529, 10.1002/hipo.22112

Wilczynski, 2008, Important role of matrix metalloproteinase 9 in epileptogenesis, J. Cell Biol., 180, 1021, 10.1083/jcb.200708213

Williams, 2003, Learning and behavior in children with epilepsy, Epilepsy Behav., 4, 107, 10.1016/s1525-5050(03)00024-6

Wlodarczyk, 2011, Extracellular matrix molecules, their receptors and secreted proteases in synaptic plasticity, Dev. Neurobiol., 71, 1040, 10.1002/dneu.20958

Wong, 2005, Modulation of dendritic spines in epilepsy: cellular mechanisms and functional implications, Epilepsy Behav., 7, 569, 10.1016/j.yebeh.2005.08.007

Wong, 2013, Dendritic spine pathology in epilepsy: cause or consequence?, Neuroscience, 251, 141, 10.1016/j.neuroscience.2012.03.048

Yan, 2006, Matrix metalloproteinase-9 degrades amyloid-β fibrils in vitro and compact plaques in situ, J. Biol. Chem., 281, 24566, 10.1074/jbc.m602440200

Yang, 2010, Increased intranuclear matrix metalloproteinase activity in neurons interferes with oxidative DNA repair in focal cerebral ischemia, J. Neurochem., 112, 134, 10.1111/j.1471-4159.2009.06433.x

Ye, 2000, Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases, Matrix Biol., 19, 623, 10.1016/s0945-053x(00)00102-5

Yeghiazaryan, 2012, Fine-structural distribution of MMP-2 and MMP-9 activities in the rat skeletal muscle upon training: a study by high-resolution in situ zymography, Histochem. Cell Biol., 138, 75, 10.1007/s00418-012-0940-5

Yoshimura, 2005, GSK-3β regulates phosphorylation of CRMP-2 and neuronal polarity, Cell, 120, 137, 10.1016/j.cell.2004.11.012

Yu, 2000, Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis, Genes Dev., 14, 163, 10.1101/gad.14.2.163

Yuan, 2013, A functional polymorphism at miR-491–5p binding site in the 3’-UTR of MMP-9 gene confers increased risk for atherosclerotic cerebral infarction in a Chinese population, Atherosclerosis, 226, 447, 10.1016/j.atherosclerosis.2012.11.026

Zagulska-Szymczak, 2001, Kainate-induced genes in the hippocampus: lessons from expression patterns, Neurochem. Int., 38, 485, 10.1016/s0197-0186(00)00101-7

Zhang, 2000, Regional and age-related expression of gelatinases in the brains of young and old rats after treatment with kainic acid, Neurosci. Lett., 295, 9, 10.1016/s0304-3940(00)01582-2

Zhou, 2007, Chronic alcohol drinking alters neuronal dendritic spines in the brain reward center nucleus accumbens, Brain Res., 1134, 148, 10.1016/j.brainres.2006.11.046

Zhu, 2013, Recent progress in tissue optical clearing, Laser Photon. Rev., 7, 732, 10.1002/lpor.201200056

Zimowska, 2013, Nuclear MMP-9 role in the regulation of rat skeletal myoblasts proliferation, Biol. Cell, 105, 334, 10.1111/boc.201300020